DeepMed Research

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

An Adaptive Intervention for Depression Among Latinos Living With HIV

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Augment w/mHealth
Behavioral: Maintenance
Behavioral: Switch to CBT & mHealth
Behavioral: Augment w/BAT & mHealth

First Posted Date: 2018-09-12

Last Posted Date: 2024-10-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT03668379

Locations: 🇺🇸
Ward 86 HIV Clinic, Zuckerberg San Francisco General Hospital, San Francisco, California, United States

Sphenopalatine Ganglion Blocks RCT

Phase 4

Completed

Conditions: Migraine

Interventions: Drug: Ropivacaine
Drug: Placebo
Drug: Bupivacaine
Drug: Lidocaine

First Posted Date: 2018-09-12

Last Posted Date: 2021-10-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT03666663

Locations: 🇺🇸
UCSF Headache Center, San Francisco, California, United States

The Reducing Risk Study

Not Applicable

Recruiting

Conditions: Insomnia
Delayed Sleep Phase

Interventions: Behavioral: mTranS-C
Behavioral: Control

First Posted Date: 2018-09-11

Last Posted Date: 2023-11-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT03665337

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris

Phase 4

Terminated

Conditions: Psoriasis Vulgaris
Psoriasis

Interventions: Device: Phototherapy Only
Drug: Crude Coal Tar Only
Other: Goeckerman Therapy

First Posted Date: 2018-09-07

Last Posted Date: 2025-05-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 4

Registration Number: NCT03662685

Locations: 🇺🇸
UCSF Psoriasis and Skin Treatment Center, San Francisco, California, United States

BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES

Phase 1

Terminated

Conditions: Primary Tauopathies
MAPT Mutation Carriers, Symptomatic
Traumatic Encephalopathy Syndrome
Corticobasal Degeneration Syndrome
Frontotemporal Lobar Degeneration With Tau Inclusions
Nonfluent Aphasia, Progressive

Interventions: Other: Placebo
Drug: BIIB092

First Posted Date: 2018-09-05

Last Posted Date: 2019-12-19

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 22

Registration Number: NCT03658135

Locations: 🇺🇸
UCSF Memory and Aging Center, San Francisco, California, United States

Using the Electronic Health Record to Guide Management of Newborn Weight Loss

Not Applicable

Completed

Conditions: Breastfeeding, Exclusive
Breastfeeding
Feeding, Bottle
Morbidity;Perinatal

Interventions: Other: Usual care
Other: NEWT

First Posted Date: 2018-08-31

Last Posted Date: 2020-03-26

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 2682

Registration Number: NCT03655314

Locations: 🇺🇸
University of California, San Francisco Medical Center, San Francisco, California, United States

Effect of Location of Tetanic Stimuli on Photoplethysmogram

Not Applicable

Completed

Conditions: Stress Reaction

Interventions: Device: Tetanic Stimulus

First Posted Date: 2018-08-27

Last Posted Date: 2020-05-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 12

Registration Number: NCT03648853

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

User-Friendly Spirometer and Mobile App for Self-Management and Home Monitoring of Asthma Patients

Completed

Conditions: Asthma in Children
Asthma Attack
Asthma Acute
Asthma Chronic

First Posted Date: 2018-08-22

Last Posted Date: 2020-07-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT03642418

Locations: 🇺🇸
UCSF- Benioff Children Hospital, San Francisco, California, United States

Metformin for Pulmonary Hypertension HFpEF

Phase 2

Recruiting

Conditions: Heart Failure
Pulmonary Hypertension

Interventions: Drug: Placebo oral capsule
Drug: Metformin

First Posted Date: 2018-08-14

Last Posted Date: 2025-03-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT03629340

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States
🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Phase 4

Completed

Conditions: Hepatitis C
Transplantation Disease Transmission

Interventions: Drug: Sofosbuvir/Velpatasvir
Drug: Sofosbuvir/Velpatasvir/Voxilaprevir

First Posted Date: 2018-08-08

Last Posted Date: 2021-03-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 122

Registration Number: NCT03619837

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Baylor University Medical Center - Dallas, Dallas, Texas, United States
🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy